Irie Jack's presentation had caused a huge stir. After it ended, he moved to a small conference room and hosted a Q&A session.
Today, Shen Qi saw himself as an ordinary scholar. He entered the small conference room, took a seat in a back corner, and joined Irie Jack's Q&A.
"Ladies and gentlemen, we have two hours for face-to-face discussion. In practice, that gives each person only about three minutes on average. I sincerely hope you'll visit my lab in Tokyo sometime soon. There, we can talk freely for a whole month. But for now, let's make the most of these two short hours." Irie Jack combined the impeccable politeness of the Japanese with the inexplicable confidence of an American. His exposure to multiple cultures made him seem different from the rest.
The first question came from a European scholar. "Professor Irie, your team's ACE78 has been shown to have high bioavailability in rats and beagle dogs. But I've also learned that this compound, which has subnanomolar activity, caused some unusual changes in rats and beagle dogs. Apparently, male rats injected with ACE78 grew to the size of rabbits, while female beagle dogs injected with it became extremely agitated and aggressive."
"I'm a clinical trial researcher, and the information I've received is that ACE78 is applying for clinical trial approval in the European Union. Professor Irie, I strongly agree with your views on extending human lifespans and the golden age of scientific research, but I oppose ACE78 entering clinical trials because this investigational drug carries extremely high risks."
The very first question was pointed, even critical.
This was no longer a purely chemical issue; it touched on many other matters.
Chemistry today was vastly different from the chemistry of Nobel's era.
Biology, medicine, physics, mathematics, Computer Science, and even social